Open Daily: 10am - 10pm | Alley door pickup 10am - 7pm 3038 Hennepin Ave Minneapolis, MN
612-822-4611

  • Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Pharmaceutical Price Controls in OECD Countries: Implications for U.S. Consumers, Pricing, Research and Development, and Innovation

Pharmaceutical Price Controls in OECD Countries: Implications for U.S. Consumers, Pricing, Research and Development, and Innovation

U. S. Department of Commerce

Paperback

Business General

ISBN10: 1496025598
ISBN13: 9781496025593
Publisher: Createspace
Published: Dec 31 2004
Pages: 124
Weight: 0.67
Height: 0.26 Width: 8.50 Depth: 11.02
Language: English
This report details the effect of price controls imposed by various U.S. trade partners on pharmaceutical prices, R&D, innovation, and U.S. consumers. The study examined the drug price regulatory systems of 11 OECD countries. A quantitative analysis of prices, revenues, and R&D effects based on available data was also conducted for nine OECD countries. For reasons explained in the report, two of these nine countries were excluded from further consideration. The results from the remaining six countries were then extrapolated to the total patented markets of five additional OECD countries. Thus, the final estimates of the impact of price controls on R&D and innovation are based on an analysis of 11 OECD countries.

Also in

Business General

View All